Global Generics


Jonathan Lutinski is an associate in the Washington, D.C., office of Wilson Sonsini Goodrich & Rosati, where he is a member of the antitrust practice.

Prior to joining the firm, Jonathan spent four years as an attorney in the Health Care Division of the Federal Trade Commission's Bureau of Competition. While at the FTC, Jonathan investigated antitrust matters in the healthcare industry and was part of the litigation teams in FTC v. Warner Chilcott Holdings Co. III, et al. (D.D.C.) and FTC v. Actavis, Inc., et al. (N.D. Ga.).

  • J.D., The George Washington University Law School, 2005
    With Honors
  • B.S.B.A., Finance, Washington University in St. Louis, 2002
    Summa Cum Laude
  • Member, American Health Lawyers Association
  • Co-author with S. Sher and B. Tennis, "The Role of Antitrust in Evaluating the Competitive Impact of Patent Pooling Arrangements," The Sedona Conference Law Journal, Vol. 13, Fall 2012
  • Co-author with S. Silber and C. Armour, "Third Circuit Breathes New Life into FTC Efforts to Block Pharmaceutical Patent Settlements," New Pharma Thinkers, July 27, 2012
  • Co-author with S. Silber and R. Taylon, "Abuse of the FDA Citizen Petition Process: Ripe for Antitrust Challenge?" Antitrust Health Care Chronicle, Health Care and Pharmaceuticals Committee, ABA Section of Antitrust Law, Vol. 25, No. 2, January 2012
  • Co-author with C. Biggio, R. Shehadeh, and S. Sher, "The Emerging Role of Open-Source Software in Merger Analysis," Sweet & Maxwell, reprinted from European Competition Law Review, Issue 7, 2011
  • Speaker, "The Future of Reverse Payment Patent Settlements in Canada after the U.S. Supreme Court's Actavis Decision," Intellectual Property Institute of Canada, September 12, 2013
  • Moderator, "FTC and DOJ IP/Antitrust Enforcement Priorities," Antitrust Committee, ABA Section of Intellectual Property Law, June 26, 2013
  • Speaker, "Recent Antitrust Developments in the Health Care and Pharmaceutical Markets: October and November 2012," Health Care and Pharmaceuticals Committee, ABA Section of Antitrust Law, December 6, 2012
  • Moderator, "FDA Citizen Petitions and Noerr Immunity: Policy Questions and Litigation Tactics to Consider," ABA Antitrust Section's Exemptions & Immunities Committee and Health Care & Pharmaceuticals Committee, November 5, 2012
  • Bar of the District of Columbia
  • State Bar of California

Contact Information

1700 K Street, NW
Fifth Floor
Washington, DC 20006
Phone | 202-973-8816
Fax | 202-973-8899

Email | Jonathan

Print to PDF